Laryngopharyngeal reflux (LPR), an extraesophageal variant of gastroesophageal reflux
disease, is associated with hoarseness, chronic cough, throat-clearing, sore throat, and …

Purpose: The diagnosis of laryngopharyngeal reflux (LPR) is commonly based on non-
specific symptoms and findings and a positive response to an empirical therapeutic trial. The …

Objective To assess the use of proton pump inhibitors (PPIs) to treat persistent throat
symptoms. Design Pragmatic, double blind, placebo controlled, randomised trial. Setting …

Background Diagnosis and treatment of presumed laryngopharyngeal reflux (LPR) remain
controversial. Empiric medication trials remain widespread for suspected LPR despite …

Objective To investigate worldwide practices of otolaryngologists in the management of
laryngopharyngeal reflux (LPR). Methods An online survey was sent on the management of …

Objectives Management of laryngopharyngeal reflux (LPR) typically comprises alginates
and proton pump inhibitors (PPIs) alone or in combination, yet evidence to support any …

Our understanding of the relationship between gastro-oesophageal reflux and respiratory
disease has recently undergone important changes. The previous paradigm of airway reflux …

Objectives: To investigate the current trends in management of laryngopharyngeal reflux
(LPR) among young European otolaryngologists and general practitioners (GP). Methods …

The role of proton pump inhibitor in the treatment of laryngopharygneal reflux disease
(LPRD) has been advocated, but there has been few reports dealing with large population …

Objectives Gastroesophageal reflux recommended treatment (dose and duration) with
proton‐pump inhibitor (PPI) compared to placebo significantly reduces the signs and …